← Back to Screener
Stereotaxis, Inc. Common Stock (STXS)
Price$1.78
Value ScoreD
Growth ScoreD
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-35.57%
Price vs S&P 500 (4W)-6.31%
VGM Score28.98
Market Capitalization$173.97M
All Metrics
Book Value / Share (Quarterly)$0.20
P/TBV (Annual)17.46x
Revenue Growth (3Y)4.77%
Cash Flow / Share (Quarterly)$-0.16
Price vs S&P 500 (YTD)-30.77%
Gross Margin (TTM)53.86%
Net Profit Margin (TTM)-69.50%
EPS (TTM)$-0.23
10-Day Avg Trading Volume0.41M
EPS Excl Extra (TTM)$-0.23
Revenue Growth (5Y)3.99%
EPS (Annual)$-0.24
ROI (Annual)-115.61%
Gross Margin (Annual)52.73%
Net Profit Margin (5Y Avg)-65.83%
Cash / Share (Quarterly)$0.15
Revenue Growth QoQ (YoY)-15.81%
ROA (Last FY)-41.42%
Revenue Growth TTM (YoY)13.40%
EBITD / Share (TTM)$-0.23
ROE (5Y Avg)-100.98%
Operating Margin (TTM)-72.63%
Cash Flow / Share (Annual)$-0.14
P/B Ratio8.88x
P/B Ratio (Quarterly)9.15x
Net Income / Employee (Annual)$-165,200
EV / Revenue (TTM)5.11x
Net Interest Coverage (TTM)-1071.00x
ROA (TTM)-44.93%
EV / EBITDA (TTM)346.42x
EPS Incl Extra (Annual)$-0.24
Current Ratio (Annual)1.51x
Quick Ratio (Quarterly)1.05x
3-Month Avg Trading Volume0.44M
52-Week Price Return-20.54%
Revenue / Employee (TTM)$238,100
Tangible BV / Share (Quarterly)$0.14
P/S Ratio (Annual)5.37x
Asset Turnover (Annual)0.62x
52-Week High$3.59
Operating Margin (5Y Avg)-68.12%
EPS Excl Extra (Annual)$-0.24
CapEx CAGR (5Y)5.85%
Tangible BV CAGR (5Y)28.64%
26-Week Price Return-27.64%
Quick Ratio (Annual)1.05x
13-Week Price Return-18.72%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.56x
Enterprise Value$159.36M
Revenue / Share Growth (5Y)-0.55%
Asset Turnover (TTM)0.65x
Book Value / Share Growth (5Y)-18.49%
Revenue / Employee (Annual)$247,200
Inventory Turnover (Annual)1.71x
Pretax Margin (Annual)-66.85%
Cash / Share (Annual)$0.14
3-Month Return Std Dev47.47%
Gross Margin (5Y Avg)58.88%
Net Income / Employee (TTM)$-165,500
ROE (Last FY)-115.61%
Net Interest Coverage (Annual)-156.00x
EPS Basic Excl Extra (Annual)$-0.24
P/FCF (TTM)137.64x
Receivables Turnover (TTM)6.48x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.23
Receivables Turnover (Annual)6.70x
ROI (TTM)-153.21%
P/S Ratio (TTM)5.58x
Pretax Margin (5Y Avg)-65.83%
Revenue / Share (Annual)$0.36
Tangible BV / Share (Annual)$0.13
Price vs S&P 500 (52W)-44.90%
Year-to-Date Return-22.61%
5-Day Price Return-8.25%
EPS Normalized (Annual)$-0.24
ROA (5Y Avg)-38.82%
Net Profit Margin (Annual)-66.85%
Month-to-Date Return-10.10%
Cash Flow / Share (TTM)$-0.26
EBITD / Share (Annual)$-0.24
Operating Margin (Annual)-69.81%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-100.98%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.23
P/TBV (Quarterly)13.38x
P/B Ratio (Annual)11.47x
Inventory Turnover (TTM)1.42x
Pretax Margin (TTM)-69.50%
Book Value / Share (Annual)$0.20
Price vs S&P 500 (13W)-26.98%
Beta1.38x
Revenue / Share (TTM)$0.32
ROE (TTM)-153.21%
52-Week Low$1.70
vGradeD
gGradeD
mGradeD
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-0.06est. -0.05
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.09
4.09
4.09
4.10
Industry Peers — Electromedical Equipment(31)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
STXSStereotaxis, Inc. Common Stock | D | D | D | $1.78 |
| MDTMedtronic plc | B | C | C | $81.67 |
| MASIMasimo Corporation | D | D | B | $178.82 |
| LIVNLivaNova PLC Ordinary Shares | C | C | B | $72.36 |
| ITGRInteger Holdings Corporation | B | C | C | $91.98 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | D | $69.43 |
| AXGNAxogen, Inc. Common Stock | F | B | A | $42.80 |
| BLFSBioLife Solutions Inc. | F | B | B | $26.65 |
| CNMDCONMED Corporation | A | C | D | $35.16 |
| INMDInMode Ltd. Ordinary Shares | A | D | C | $13.54 |
| CBLLCeriBell, Inc. Common Stock | D | A | B | $18.25 |
About
Stereotaxis Inc specializes in robotic technologies for cardiac arrhythmia treatment and endovascular procedures, providing interventional labs with precision surgical systems and integrated procedural information solutions. The company generates revenue primarily through disposables and service, supplemented by systems sales, royalties, and facility subleases.